Drug Type T-lymphocyte cell therapy |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | US | 21 Mar 2024 | |
Solid tumor | Preclinical | US | Arsenal Biosciences, Inc.Startup | 21 Mar 2024 |